Status:
UNKNOWN
Resistance Exercise and Cannabis Use
Lead Sponsor:
Penn State University
Conditions:
Cannabis Use Disorder
Eligibility:
All Genders
18-30 years
Phase:
NA
Brief Summary
Cannabis is the most widely used illicit drug and rates of hazardous use, and cannabis use disorders (CUDs), have continued to rise in recent years. The highest rates of use and CUDs are seen in young...
Detailed Description
Cannabis is the most widely used illicit drug and rates of hazardous use, and cannabis use disorders (CUDs), have continued to rise in recent years. The highest rates of use and CUDs are seen in young...
Eligibility Criteria
Inclusion
- Healthy individuals between the ages of 18-30 years who currently meet for a moderate or severe cannabis use disorder according to DSM-5 criteria.
- Untrained (no structured exercise program for at least the previous 6 months) as verified by self-report on a physical activity form.
- No previous bone or muscle problems or previous injuries that would prevent free movement about the shoulder, hip, knee or ankle, or increase the risk of discomfort or injury during exercise. No ongoing back problems.
- No known endocrine disorders (including, but not limited to Hyperthyroidism, Hypothyroidism, Hyperparathyroidism, Cushing's Syndrome, Diabetes mellitus, metabolic syndrome or other inflammatory disorders).
- No history of blood clotting disorders.
- Able to read English and complete study assessments
- Voluntarily provide informed consent and sign the informed consent document.
- Able to provide negative toxicology screenings for substances, except for cannabis, at intake.
Exclusion
- Meet current criteria for a moderate or severe substance use disorder for any other substance besides cannabis
- Have any current psychiatric disorders with acute symptoms (i.e., psychosis, suicidal, homicidal, current mania).
- Younger or older than the specified age range of 18-30.
- Any endocrine, bone, muscle problems, previous injuries, back problems, or blood clotting disorders.
- Cardiac and severe respiratory illnesses (i.e. arrhythmias, enlarged heart, COPD) -
Key Trial Info
Start Date :
February 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2024
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT03867786
Start Date
February 1 2023
End Date
December 1 2024
Last Update
January 20 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.